Last Updated: June 25, 2026

DEOXYCHOLIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Deoxycholic, and what generic alternatives are available?

Deoxycholic is a drug marketed by Wilshire Pharms Inc and is included in one NDA.

The generic ingredient in DEOXYCHOLIC is deoxycholic acid. There are thirty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the deoxycholic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Deoxycholic

A generic version of DEOXYCHOLIC was approved as deoxycholic acid by WILSHIRE PHARMS INC on April 2nd, 2021.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DEOXYCHOLIC?
  • What are the global sales for DEOXYCHOLIC?
  • What is Average Wholesale Price for DEOXYCHOLIC?
Summary for DEOXYCHOLIC
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:DEOXYCHOLIC at DailyMed

US Patents and Regulatory Information for DEOXYCHOLIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wilshire Pharms Inc DEOXYCHOLIC ACID deoxycholic acid SOLUTION;SUBCUTANEOUS 212296-001 Apr 2, 2021 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.